|
|
Qgey Federal government braces for a long 鈥?and expensive 鈥?road to recovery from Baltimore bridge collapse
CAPE CANAVERAL, Fla. 鈥?NASA is kicking off its new moon program with a test flight of a brand-new rocket and capsule.Liftoff was slated for early Wednesday morning from Ken stanley cup usa nedy Space Center in Florida. The test fli stanley cup ght aims to send an empty crew capsule into a far-flung lunar orbit, 50 years after NASA s famed Apollo moonshots.The project is years late and billions over budget. The price tag for the test flight: more than $4 billion.A rundown of the new rocket and capsule, part of NASAs Artemis program, named after Apollos mythological twin sister:ROCKET POWERAt 322 feet 98 meters , the new rocket is shorter and slimmer than the Saturn V rockets that hurled 24 Apollo astronauts to the moon a half-century ago. But its mightier, packing 8.8 million pounds 4 million kilograms of thrust. It s called the Space Launch System rocket, SLS for short, although a less clunky name is under discussion. Unlike the streamlined Saturn V, the new rocket has a pair of side boosters refashioned from NASAs space shuttles. The boosters peel away after two minutes, just like the shuttle boosters. The core stage keeps firing before crashing into the Pacific. Less than two hours after liftoff, an upper stage sends the capsule, Orion, racing toward the moon.MOONSHIPNASA s high-tech, automated Orion capsule is named after the constellation, among the night skys brightest. At 11 feet 3 meters tall, it s roomier than Ap stanley cup ollo s capsule, seating four astronauts instead of three. For the test flight, a Ksbl Parents of students with special needs face uncertain support in the fall
Pharmaceutical company Eli Lilly plans on distributing a treatm stanley tumbler ent for coronavirus patients this week. The Food and Drug Administration FDA just gave it the green light.The antibody treatment is for patients over the age of 65 who have mild to moderate symptoms. Patients who are 12 years and up are also eligible if they have an underlying health condition.The FDA approval comes at a time when cases are going up again and hospitals are struggling to treat so many patients.Infectious disease experts say one of the biggest challenges for hospitals right now is to figure out where they want to administer the treatment.It is given through an IV and usually, IV treatments are given in an outpatient setting to cancer patients. If you re talking about hospitals that have infusion centers for cancer and chemo stanley mug therapy, that s not generally a place where they re going to feel comfortable taking COVID-19 patients in the contagi stanley thermos ous phase of their disease, because they also have highly immuno-compromised patients there, said Dr. Shira Doron, a hospital epidemiologist at Tufts Medical Center.Some hospitals in the U.S. already have the resources and space to administer the treatment to COVID-19 patients, but many still don t.Another option would be to administer it in an emergency room, while still following the same criteria for who receives it.While there are guidelines for who receives it, cases are rising. That could add another limitation to how many patients get the new antibody trea |
|
发表于 2024-11-10 02:22:45